“A&D Pharma is currently analyzing this takeover in order to accelerate its expansion outside Romania and the development of its marketing and sales division. […] This acquisition is a step forward in our strategy to consolidate our position,” said Robert Popescu, chief executive officer of the company. The acquisition is dependent on the agreement of the sellers, as well as a banking syndicate which has offered A&D Pharma a EUR 100 million refinancing loan. If the acquisition gets the green light, it should be completed by the end of this year. A&D Pharma runs the Sensiblu chains of pharmacies in Romania, as well as the Mediplus drug distribution business. The group posted a EUR 503 million turnover last year. Its shares are traded on the London Stock Exchange.